Interleukin-39 exacerbates concanavalin A-induced liver injury.
Yan LiLuping GongLinjie WengXiuhe PanChaobo LiuMingcai LiPublished in: Immunopharmacology and immunotoxicology (2021)
Our results suggest that IL-39 can exacerbate ConA-induced hepatitis and may be a therapeutic target in inflammatory liver disease.